4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-026991
Director sold 580 shares at an average $348.28 ($202,004)
- Director acquired 1,168 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bhatia Sangeeta N. · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-01 | Grant or award : show line 1 in the form 10b5-1 | +1,168 | 5,208 | D | ||
| 2023-05-02 | Sale : show line 2 in the form 10b5-1 | −62 | $345.93 | $21,448 | 5,146 | D |
| 2023-05-02 | Sale : show line 3 in the form 10b5-1 | −172 | $346.69 | $59,631 | 4,974 | D |
| 2023-05-02 | Sale : show line 4 in the form 10b5-1 | −120 | $348.16 | $41,779 | 4,854 | D |
| 2023-05-02 | Sale : show line 5 in the form 10b5-1 | −163 | $349.82 | $57,021 | 4,691 | D |
| 2023-05-02 | Sale : show line 6 in the form 10b5-1 | −63 | $351.20 | $22,126 | 4,628 | D |
| Open-market sales · 580 sh · avg $348.28 · $202,004 | ||||||
Loading xslF345X04/doc4.xml…